Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinta Mizuno

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Inflammatory Bowel Diseases|April 24, 2024
Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled TrialTomohiro Fukuda, Yasuhiro Aoki, Hiroki Kiyohara, et al.
Journal of Gastroenterology|September 19, 2019
Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO studyMakoto Naganuma, Shinya Sugimoto, Tomohiro Fukuda, et al.
Digestion|May 8, 2014
Risk and management of intra-abdominal abscess in Crohn's disease treated with infliximabKazuaki Yoneno, Tadakazu Hisamatsu, Katsuyoshi Matsuoka, et al.
Journal of Gastroenterology|May 4, 2021
Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET studyShinichiro Shinzaki, Katsuyoshi Matsuoka, Hiroki Tanaka, et al.
Journal of Gastroenterology and Hepatology|May 3, 2019
Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurineShintaro Akiyama, Katsuyoshi Matsuoka, Kyoko Fukuda, et al.
Gastroenterology|November 28, 2017
Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative ColitisMakoto Naganuma, Shinya Sugimoto, Keiichi Mitsuyama, et al.
Journal of Gastroenterology|January 29, 2020
A nationwide, multi-center, retrospective study of symptomatic small bowel stricture in patients with Crohn's diseaseShigeki Bamba, Ryosuke Sakemi, Toshimitsu Fujii, et al.
Journal of Gastroenterology|June 21, 2018
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter studyYoichi Kakuta, Yosuke Kawai, Daisuke Okamoto, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Inflammatory Bowel Diseases|April 24, 2024
Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled TrialTomohiro Fukuda, Yasuhiro Aoki, Hiroki Kiyohara, et al.
Journal of Gastroenterology|September 19, 2019
Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO studyMakoto Naganuma, Shinya Sugimoto, Tomohiro Fukuda, et al.
Digestion|May 8, 2014
Risk and management of intra-abdominal abscess in Crohn's disease treated with infliximabKazuaki Yoneno, Tadakazu Hisamatsu, Katsuyoshi Matsuoka, et al.
Journal of Gastroenterology|May 4, 2021
Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET studyShinichiro Shinzaki, Katsuyoshi Matsuoka, Hiroki Tanaka, et al.
Journal of Gastroenterology and Hepatology|May 3, 2019
Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurineShintaro Akiyama, Katsuyoshi Matsuoka, Kyoko Fukuda, et al.
Gastroenterology|November 28, 2017
Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative ColitisMakoto Naganuma, Shinya Sugimoto, Keiichi Mitsuyama, et al.
Journal of Gastroenterology|January 29, 2020
A nationwide, multi-center, retrospective study of symptomatic small bowel stricture in patients with Crohn's diseaseShigeki Bamba, Ryosuke Sakemi, Toshimitsu Fujii, et al.
Journal of Gastroenterology|June 21, 2018
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter studyYoichi Kakuta, Yosuke Kawai, Daisuke Okamoto, et al.
Pageof 6